(63%) patients -higher than the predictive values of ALT. Serum alanine aminotransferase (ALT) values did not correlate with the degree of histological inflammation (r=0.39) but did correlate mildly with the extent of hepatic fibrosis (r=0.51). There were no significant correlations of the other variables with histological inflammation or fibrosis.
COMMENTARY
Although Menghini (2) described the 'one second' liver biopsy over 40 years ago, the liver biopsy has maintained its position in modern medicine as the cornerstone to understanding liver diseases. In patients with hepatitis C, the liver biopsy can provide important information regarding the extent and severity of the hepatitis, the likelihood of progression to cirrhosis and the potential response to medical therapy (3, 4) . However, the acquisition of this valuable information occurs at the expense of performing an invasive procedure with inherent risks and complications, including death (5-7). Thus, the search for noninvasive, surrogate markers that can predict the underlying histopathology is enticing.
Many surrogate markers have been investigated, of which the aminotransferases are the best studied. Along with AST, the AST to ALT ratio has been suggested as a predictor of histopathology by many studies; however, other Liver enzymes as surrogate markers of hepatitis C histopathology -Avoiding the liver biopsy needle?
Stephen GM Wong BSc(Med) MD FRCPC, Eric M Yoshida MD MHSc FRCPC studies have produced conflicting results (8) (9) (10) (11) . The present study has shed further light in this area, because AST, and not ALT, levels seem to correlate positively with hepatic inflammation and fibrosis using Desmet's modified histological activity index scale. Nevertheless, despite the liver biopsy technique remaining essentially unchanged over the years, the hepatitis histopathology classifications have undergone many revisions. The current grading and staging classification system described by Batts and Ludwig (12) in 1995 has now become the standard. Surrogate marker studies with this new classification system are still pending. Thus, the pursuit of a noninvasive and predictive marker for liver histology will continue as we try to avoid the liver biopsy needle for our patients.
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